Nektar Therapeutics NKTR Stock
Nektar Therapeutics Price Chart
Nektar Therapeutics NKTR Financial and Trading Overview
| Nektar Therapeutics stock price | 66.69 USD |
| Previous Close | 60.98 USD |
| Open | 62.3 USD |
| Bid | 56.38 USD x 100 |
| Ask | 74.67 USD x 100 |
| Day's Range | 62.3 - 66.54 USD |
| 52 Week Range | 8.35 - 109 USD |
| Volume | 1.28M USD |
| Avg. Volume | 1.01M USD |
| Market Cap | 2.22B USD |
| Beta (5Y Monthly) | 1.151 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.93 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 153.25 USD |
NKTR Valuation Measures
| Enterprise Value | 1.64B USD |
| Trailing P/E | N/A |
| Forward P/E | -5.2298503 |
| PEG Ratio (5 yr expected) | 0.31 |
| Price/Sales (ttm) | 39.89974 |
| Price/Book (mrq) | 3.3604417 |
| Enterprise Value/Revenue | 29.391 |
| Enterprise Value/EBITDA | -13.196 |
Trading Information
Nektar Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.151 |
| 52-Week Change | 539.20% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 109 USD |
| 52 Week Low | 8.35 USD |
| 50-Day Moving Average | 74 USD |
| 200-Day Moving Average | 60.74 USD |
NKTR Share Statistics
| Avg. Volume (3 month) | 1.01M USD |
| Avg. Daily Volume (10-Days) | 839.63K USD |
| Shares Outstanding | 33.79M |
| Float | 29.14M |
| Short Ratio | 5.37 |
| % Held by Insiders | 0.44% |
| % Held by Institutions | 80.14% |
| Shares Short | 4.61M |
| Short % of Float | 15.07% |
| Short % of Shares Outstanding | 13.65% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -284.18% |
| Operating Margin (ttm) | -352.25% |
| Gross Margin | 100.00% |
| EBITDA Margin | -222.73% |
Management Effectiveness
| Return on Assets (ttm) | -15.28% |
| Return on Equity (ttm) | -53.59% |
Income Statement
| Revenue (ttm) | 55.63M USD |
| Revenue Per Share (ttm) | 2.85 USD |
| Quarterly Revenue Growth (yoy) | 3.79% |
| Gross Profit (ttm) | 55.63M USD |
| EBITDA | -123912000 USD |
| Net Income Avi to Common (ttm) | -158098000 USD |
| Diluted EPS (ttm) | -7.93 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 568.6M USD |
| Total Cash Per Share (mrq) | 16.83 USD |
| Total Debt (mrq) | 143.43M USD |
| Total Debt/Equity (mrq) | 24.89 USD |
| Current Ratio (mrq) | 10.207 |
| Book Value Per Share (mrq) | 19.551 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -203756000 USD |
| Levered Free Cash Flow (ttm) | -107228376 USD |
Profile of Nektar Therapeutics
| Country | United States |
| State | CA |
| City | San Francisco |
| Address | 455 Mission Bay Boulevard South |
| ZIP | 94158 |
| Phone | 415 482 5300 |
| Website | https://www.nektar.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 63 |
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat solid tumors and large b-cell lymphoma. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; and Merck KGaA. The company was incorporated in 1990 and is headquartered in San Francisco, California.
Q&A For Nektar Therapeutics Stock
What is a current NKTR stock price?
Nektar Therapeutics NKTR stock price today per share is 66.69 USD.
How to purchase Nektar Therapeutics stock?
You can buy NKTR shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nektar Therapeutics?
The stock symbol or ticker of Nektar Therapeutics is NKTR.
Which industry does the Nektar Therapeutics company belong to?
The Nektar Therapeutics industry is Biotechnology.
How many shares does Nektar Therapeutics have in circulation?
The max supply of Nektar Therapeutics shares is 33.79M.
What is Nektar Therapeutics Price to Earnings Ratio (PE Ratio)?
Nektar Therapeutics PE Ratio is now.
What was Nektar Therapeutics earnings per share over the trailing 12 months (TTM)?
Nektar Therapeutics EPS is -7.93 USD over the trailing 12 months.
Which sector does the Nektar Therapeutics company belong to?
The Nektar Therapeutics sector is Healthcare.
Nektar Therapeutics NKTR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Biotechnology Total Retu
XNBI
US
|
6750.7 USD — |
+0.85
|
— — | 6680.28 USD — | 6803.27 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
12546.99 USD — |
-2.24
|
— — | 12513.27 USD — | 12692.24 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6185.56 USD — |
+0.85
|
— — | 6121.03 USD — | 6233.73 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
31560.2 USD — |
-2.21
|
— — | 31469.2 USD — | 31924.72 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}